Justin Anslow is a partner in Goodwin’s Technology group and Capital Markets practice. He advises high-growth and public companies, investment banks and venture, private equity, and institutional investors on complex and market-shaping capital markets and strategic transactions, with a focus on IPOs and follow-on offerings, de-SPAC transactions, PIPE financings, and M&A transactions. His experience includes high-profile IPOs, large secondary offerings, cross-border transactions, and sponsor-backed business combinations and reverse mergers.
Justin has experience across the full lifecycle of SPAC transactions — from sponsor formation and IPO through business combination and related PIPE financings — and regularly represents target companies, SPAC sponsors, target stockholders, and lead PIPE investors in such transactions. He also advises on convertible and high-yield debt offerings. In addition to transactional matters, Justin counsels public companies on SEC reporting, disclosure strategy, and stock exchange compliance and represents many of the firms public company clients, including HubSpot, Freenome, Altimmune, and IPG Photonics. Justin’s clients operate primarily in the technology and life sciences sectors, including venture-backed and sponsor-backed companies navigating or considering the public markets.
REPRESENTATIVE MATTERS
Professional Experience
Prior to joining Goodwin, Justin was an associate in the New York office of Sheppard, Mullin, Richter & Hampton LLP.
Credentials
Education
JD
The George Washington University Law School
BBA
University of Wisconsin-Madison
Admissions
Bars
- New York
Recognition & Awards
Justin has been recognized by The Best Lawyers in America — Ones to Watch for 2024 and 2025.
